FDA postpones advisory panel meeting on Pfizer Covid-19 vaccine for younger children

Malaysia News News

FDA postpones advisory panel meeting on Pfizer Covid-19 vaccine for younger children
Malaysia Latest News,Malaysia Headlines
  • 📰 cnni
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 59%

The US Food and Drug Administration is postponing an advisory panel meeting on authorizing Pfizer’s Covid-19 vaccine in children under 5.

The US Food and Drug Administration announced Friday that it is postponing the meeting of its Vaccines and Related Biological Products Advisory Committee, originally scheduled for February 15, as"new data have recently emerged" regarding Pfizer and BioNTech's emergency use authorization request for their Covid-19 vaccine for children younger than 5.

"This will give the agency time to consider the additional data, allowing for a transparent public discussion as part of our usual scientific and regulatory processes for COVID-19 vaccines. We will provide an update on timing for the advisory committee meeting once we receive additional data on a third dose in this age group from the company's ongoing clinical trial and have an opportunity to complete an updated evaluation," acting FDA Commissioner Dr. Janet Woodcock and Dr.

Read MorePfizer said the study's independent Data Monitoring Committee supports the continuation of the trial. It believes that the data collected indicates that the vaccine is well-tolerated and supports a potential three-dose regimen. This is a developing story and will be updated.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

cnni /  🏆 326. in US

Malaysia Latest News, Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA delays public meeting for COVID-19 vaccine for children under 5 to review more dataFDA delays public meeting for COVID-19 vaccine for children under 5 to review more dataBREAKING: The FDA has delayed a public meeting for a COVID-19 vaccine for children under 5 in order to review more data.
Read more »

FDA delays public meeting for COVID-19 vaccine for children under 5 to review more dataFDA delays public meeting for COVID-19 vaccine for children under 5 to review more dataThe FDA has delayed a public meeting for a COVID-19 vaccine for children under 5 in order to review more data.
Read more »

FDA delays public meeting for COVID-19 vaccine for children under 5 to review more dataFDA delays public meeting for COVID-19 vaccine for children under 5 to review more dataThe FDA has delayed a public meeting for a COVID-19 vaccine for children under 5 in order to review more data.
Read more »

US preps 10 million doses of COVID-19 vaccine for kids under 5, pending FDA authorizationUS preps 10 million doses of COVID-19 vaccine for kids under 5, pending FDA authorizationCOVID-19 vaccines for kids under 5 have not yet been authorized, but the rollout plan is already in the works.
Read more »

Area Business Owners Hope Lifting Of Illinois COVID-19 Mask Mandate Goes SmoothlyArea Business Owners Hope Lifting Of Illinois COVID-19 Mask Mandate Goes SmoothlyWith Gov. JB Pritzker having announced he plans to lift the state’s indoor mask mandate for most places by the month’s end, business owners in Lombard said they have been anticipating such a moment for a long time.
Read more »



Render Time: 2025-03-10 10:08:28